SRPX2 interacts with the D1 and D2-D3 extracellular domains of uPAR to enhance cancer invasion and metastasis by regulating multiple downstream signaling pathways, including the integrins/FAK pathway, the MAPK pathway, and the PI3K/Akt pathway [6, 7]. Here, PLAUR is linked to cancer.